Newsline

Newsline , Society

Drug Price-Setting Policies Are Terrible — Why Are They Gaining Traction?

Posted on Tuesday, October 8, 2024
|
by Outside Contributor
|
6 Comments
|
Print

As we head into the final month of what has already been an unprecedented election season, candidate and party platforms are beginning to come to fruition.

Campaign promises, whether aspirations or vows to continue with existing policies, are at the forefront of many voters’ minds. In light of this, it is crucial to discern what policies are friendly to patients and which are not — most notably, price controls that have dominated recent headlines.

In 2022, millions of Medicare patients were promised that the Inflation Reduction Act (IRA) would deliver lower out-of-pocket spending and improved access to medicines and care. The administration stands by its claims two years later, but the results are much more mixed.

Overall, the IRA is increasing premiums and limiting choices. The law fundamentally broke Medicare Part D, a critical program that helps seniors access their medications. This year, average senior premiums have gone up 21 percent, which is expected to continue climbing in 2025. To make matters worse, despite increased payments, the number of prescription drug plans that seniors can choose from has fallen 25 percent since 2020. In fact, the number of prescription drug plans is at its lowest point since the program’s inception — less than half what it was in 2006.

Recently, the administration announced a “demo” plan to attempt to tamp down the high premiums the law caused. This program will aid big insurers by artificially and temporarily shielding spiking premiums ahead of the election. This money is out of the Medicare trust fund that goes into the pockets of insurance companies.

What’s even more concerning is that the IRA’s sponsors don’t just want to stop there. Proponents want to expand the IRA’s price controls to 15, possibly even 50 drugs per negotiation. What is unclear, however, is why. Seniors have already expressed concerns the law is disrupting their access to critical medicines and forcing them to spend more on healthcare. With all of this disruption, why not focus on addressing the consequences of a hastily written and passed law instead of doubling down?

The law threatens the development of treatments for chronic disease — medicines that seniors disproportionately rely on. Shouldn’t the IRA’s architects pause to ensure no more damage is done and determine if the program needs to be walked back if it’s as bad as experts warn? Unfortunately, many lawmakers are turning a blind eye to the side effects because the IRA is a staple healthcare platform item.

It’s time that politicians serving or hoping to serve at the highest levels of government put all patients first. As things heat up, it is critical that all parties be aware of the negative effects of price-setting policies — from drug price “negotiations” to the proposal to combat grocery “price gouging” — will have on Americans. 

In the case of healthcare, price controls will disrupt the Medicare program that Americans rely on to access the medications and therapies they need. They may appear as an appealing “quick fix” to high drug costs in America, but, in truth, these policies are just an example of taking the easy way out.

Reprinted with permission from the DC Journal by Mark Gibbons.

The opinions expressed by columnists are their own and do not necessarily represent the views of AMAC or AMAC Action.

Share this article:
Subscribe
Notify of
guest
6 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
Jerry
Jerry
1 month ago

Anyone thinking about voting for a democrat in this election needs to have their head examined. I have known a few sensible democrats but I don’t know any running in this election.

Kathryn Davis
Kathryn Davis
1 month ago

Folks of all ages are going to die at an early age of all sorts of medical conditions that our country has learned to treat successfully. We are about to become a Third World. What a shame!

Jim Johnson
Jim Johnson
1 month ago

The majority of people in government have never run anything. In fact, most have never done anything in the private sector. Instead, they have gone from public servant to totalitarian master. They do not now, nor have they ever, been concerned about the effects of their policies. All that matters is control over the populace. Constitutional government in the U. S. Is all but dead. This article is a complaint about drug prices, but it’s just another consequence of funny money. The dollar is valueless. The Constitution replaced the Articles of Convention to avoid this. Plus ca change, etc.

Laura Bentz
Laura Bentz
1 month ago

Congress always goes for the “quick fix” and so does the whole healthcare system. The whole thing need reform or something’s going to go bankrupt. And, if we were healthier in our eating habits and lifestyle, maybe we wouldn’t even need those drugs in the first place but that would disrupt the Big Pharma cash cow…

Burkhart Ron
Burkhart Ron
1 month ago

The problem is the PBM’s have inflated the price of the drugs the Doctor prescribes. If we could reign in the PBM price manipulations, kickbacks, and clawbacks, it may change the “traction” price control is currently experiencing.

Biden Administration
trump at podium with american flag behind him
On October 20, 2016, Lieutenant Governor Kathy Hochul cut the ribbon at the new Taste NY Long Island Welcome Center.
Senate Majority Leader Chuck Schumer (D-NY) gives remarks before President Joe Biden signs the Infrastructure Investment and Jobs Act, Monday, November 15, 2021, on the South Lawn of the White House. (Official White House Photo by Cameron Smith)

Stay informed! Subscribe to our Daily Newsletter.

"*" indicates required fields

6
0
Would love your thoughts, please comment.x
()
x

Subscribe to AMAC Daily News and Games